regulatory status comes up often in conversation and rarely with the context attached. Here we lay out the basics in order, then work through the practical considerations.
Updated 2026-02-19. Numbers and descriptions here follow the published literature rather than marketing material.
AOD-9604 drew attention in the 1990s and 2000s as a potential anti-obesity agent. Early work explored both injectable and oral routes, which is unusual for a peptide of this size. Animal studies reported changes in fat metabolism without the growth-promoting or insulin-like effects associated with full-length growth hormone. Subsequent human trials produced mixed or modest results, and the compound did not obtain regulatory approval for weight management in major markets. It remains known mainly through research literature, sports anti-doping listings, and non-approved supplement advertising.
AOD-9604 is prohibited in sport by the World Anti-Doping Agency under the peptide hormone class. Its presence in a sample can be detected through mass spectrometry-based methods, although the exact assay depends on the laboratory. In research settings, material is often supplied as a lyophilized powder for reconstitution. Buyers and researchers should note that products labeled AOD-9604 may vary in purity and actual peptide content. Analytical certificates and independent testing are common ways to verify identity, but no global harmonized standard exists for all commercial lots.
AOD-9604 is a synthetic peptide that corresponds to a short section of human growth hormone. It is commonly identified as hGH fragment 176-191 because its sequence matches residues at the C-terminal end of the hormone. The molecule contains sixteen amino acids and is made by solid-phase peptide synthesis. Researchers study it for metabolic effects rather than for the growth-promoting actions associated with full human growth hormone. Its small size distinguishes it from the complete 191-amino-acid hormone.
Several names appear in scientific and commercial settings. AOD9604 and AOD-9604 are development codes used interchangeably, while hGH fragment 176-191 describes the same region. The peptide includes a disulfide bond between two cysteine residues, which helps shape its three-dimensional structure. Different suppliers may provide acetate or other salt forms, and purity can vary. These differences matter because analytical tests and biological assays can respond to the specific form being studied.
| Property | Value | Notes |
|---|---|---|
| Molecular class | Synthetic peptide | Fragment analog of human growth hormone |
| Sequence basis | hGH 176–191 region | Modified C-terminal fragment |
| Common synonyms | AOD-9604; AOD9604; hGH fragment | Research and trade names vary |
| Regulatory status | Not approved as a drug | Prohibited in competitive sport |
| Research code | AOD9604 | Used in scientific and patent literature |
Regulatory bodies have taken different approaches to AOD-9604. It is not approved as a prescription medicine by major agencies such as the U.S. Food and Drug Administration or the European Medicines Agency. In sport, the World Anti-Doping Agency prohibits peptide hormones, growth factors, and related substances, and AOD-9604 has been treated as a prohibited substance. These regulatory decisions reflect concerns about safety, efficacy, and potential misuse rather than proof of benefit.
Research on AOD-9604 also examines how the peptide is measured in biological samples. Analytical methods may include liquid chromatography coupled with mass spectrometry, immunoassays, or both. Detection can be challenging because the peptide is small and may be present at low concentrations. Published methods vary in sensitivity and specificity, so comparative interpretation requires attention to validation details. The presence of related hGH fragments can complicate identification in some matrices.
AOD-9604 has been investigated mainly in the context of body fat and metabolic endpoints. Some early animal and small human studies reported changes in fat mass or lipid markers, but findings were not uniform. Larger, well-controlled trials that would establish efficacy are lacking in the public literature. As a result, claims about weight loss or metabolic benefit remain investigational rather than established. The distinction between a research finding and a proven clinical outcome is central to discussing this peptide.
In laboratory settings, AOD-9604 is commonly supplied as a lyophilized powder and stored cold to limit degradation. Reconstituted solutions are typically kept refrigerated or frozen, depending on the buffer and concentration, and protected from repeated freeze-thaw cycles. Stability can be influenced by pH, temperature, and the presence of proteases. Purity is usually assessed by high-performance liquid chromatography and mass spectrometry. These practices support reproducibility, but they do not imply safety or efficacy for any human use.
Regulatory status: AOD-9604 is not approved as a therapeutic drug in the United States, European Union, or other major markets. It is listed by the World Anti-Doping Agency as a prohibited substance in sport, specifically under growth hormone fragments. Many jurisdictions restrict its sale for human consumption. Products marketed online may not meet pharmaceutical quality standards. The legal status varies by country and often depends on whether the material is presented as a research chemical, supplement, or drug.
Detection and characterization of AOD-9604 in research and anti-doping settings typically rely on mass spectrometry coupled with liquid chromatography. These methods can identify the peptide by its mass and fragmentation pattern. Immunoassays may also be used in some screening contexts, but they can cross-react with related peptides. Because the molecule is small and may be present at low concentrations, sample preparation and method validation are important. Confirmatory analysis usually requires comparison with a certified reference standard.
Regulatory status varies by country. In the United States, AOD-9604 is not approved as a prescription drug. It is sometimes sold as a research chemical or dietary supplement, though such marketing may fall outside legal frameworks. The World Anti-Doping Agency prohibits its use in sport. Researchers must obtain it through legitimate suppliers and follow institutional rules. Its legal classification continues to evolve as authorities increasingly assess peptide products more broadly.
AOD-9604 is a synthetic peptide whose sequence matches the C-terminal fragment of human growth hormone, specifically residues 176 through 191. This region differs from the full hormone in its receptor interactions. The peptide is not a growth hormone secretagogue and does not bind the growth hormone receptor in the same manner. Researchers have examined it for effects on lipid metabolism, but its exact pharmacological profile remains an active area of study.
A further derivative of rasagiline, ladostigil ([N-propargyl-(3R)-aminoindan-5-yl]-N-propylcarbamate), a dual MAO-B inhibitor and acetylcholinesterase inhibitor, was developed for treatment of Alzheimer's disease and other conditions but was ultimately never introduced for medical use.
=== Seed germination === There are two types of seed within each pod – reddish-dark and dark (black). The ratio between these seeds varies from 1:20 to 1:5, with darker seeds outnumbering lighter seeds. Reddish-dark seeds have a thinner coat and they germinate earlier than black seeds that have not first been acid treated. "Dark seeds have a harder seed coat and require various pretreatments to ensure good germination rates." Although the seeds' usual germination rate has been reported at 75%, germination can be improved by scalding for about 7 minutes, then soaking seeds in hot water overnight prior to planting. Locust tree seedlings "can be established vegetatively in nursery beds by grafting or budding, or by rooting adult cuttings." These methods have shown good results in 11- to 25-year-old trees in Burkina Faso and Nigeria.
== Terminology == Eras cannot easily be defined for periodization, the process of categorizing the past into quantified, named blocks of time for the purpose of analysis. 1500 is an approximate starting period for the modern era because many major events caused the Western world to change around then: from the fall of Constantinople (1453), Gutenberg's moveable type printing press (1450s), and Christopher Columbus's voyage to the Americas (1492), to the Reformation begun with Martin Luther's Ninety-five Theses (1517). The term "modern" was coined shortly before 1585 to describe the beginning of a new era. It was long thought that the term "early modern" was invented either in the 1930s, to distinguish the time between the Middle Ages and late Enlightenment (1800), or the mid-20th century, and only gained traction in the 1960s. Justus Nipperdey pointed to its widespread usage by American historians around 1900 already, adding: 'In the interwar years the term permeated all areas of professional activity from textbooks and graduate school seminars to conferences, research articles, and job descriptions.' The difference between "early modern" and "modern" was defined by the French Revolution and Industrial Revolution. The European Renaissance (14th–16th centuries), which started in Italy, is an important transition period beginning in the Late Middle Ages and marking the change into early modern history.
Sources: en.wikipedia.org
As they were cut off from all European funds, finances were more stretched than ever. At one stage, Zita was reduced to making salad and spinach dishes from dandelion leaves. However, all her sons were active in the war effort. Otto promoted the dynasty's role in a post-war Europe and met regularly with Franklin Roosevelt; Robert was the Habsburg representative in London; Carl Ludwig and Felix joined the United States Army, serving with several American-raised relatives of the Mauerer line; Rudolf smuggled himself into Austria in the final days of the war to help organise the resistance. In 1945 Empress Zita celebrated her birthday on the first day of peace, 9 May. She was to spend the next two years touring the United States and Canada to raise funds for war-ravaged Austria and Hungary.
== Places == Greece (ISO 3166/NATO:GR) Grand Rapids, Michigan, United States Grand Rapids, Minnesota, United States Giurgiu County, Romania Grisons, a Swiss canton (ISO:CH-GR) Groningen (province), Netherlands (ISO:NL-GR) Province of Grosseto, Tuscany, Italy Garden Reach, Kolkata, West Bengal, India
The biosynthesis of cocaine is the natural metabolic process by which the coca plant (Erythroxylum species) produces cocaine, a tropane alkaloid, through a multi-step enzymatically catalyzed pathway beginning with ornithine or arginine and culminating in the formation of the cocaine metabolite benzoylecgonine. Large-scale biosynthesis of cocaine is unexplored. The biosynthesis of cocaine has long attracted the attention of biochemists and organic chemists. This interest is partly motivated by the strong physiological effects of cocaine, but a further incentive was the unusual bicyclic structure of the molecule. The biosynthesis can be viewed as occurring in two phases, one phase leading to the N-methylpyrrolinium ring, which is preserved in the final product. The second phase incorporates a C4 unit with formation of the bicyclic tropane core.
=== Dogs === Dogs have been used to diagnose symptomatic and asymptomatic individuals with metabolic and infectious diseases because of their highly sensitive olfaction due to a higher neuron packing density and threefold the number of functional genes encoding olfactory receptors relative to humans. This increase in receptors results in dogs possessing a 10,000 to 100,000 times higher accuracy in specially recognizing chemical messengers than humans. They have been frequently used to diagnose asymptomatic individuals with various infectious diseases such as SARS CoV-2, H1N1 Influenza, malaria, bovine virus infection, etc.
Sources: en.wikipedia.org
Dye-sub printing is a digital printing technology using full color artwork that works with polyester and polymer-coated substrates. Also referred to as digital sublimation, the process is commonly used for decorating apparel, signs and banners, as well as novelty items such as cell phone covers, plaques, coffee mugs, and other items with sublimation-friendly surfaces. The process uses the science of sublimation, in which heat and pressure are applied to a solid, turning it into a gas through an endothermic reaction without passing through the liquid phase. In sublimation printing, unique sublimation dyes are transferred to sheets of "transfer" paper via liquid gel ink through a piezoelectric print head. The ink is deposited on these high-release inkjet papers, which are used for the next step of the sublimation printing process. After the digital design is printed onto sublimation transfer sheets, it is placed on a heat press along with the substrate to be sublimated. In order to transfer the image from the paper to the substrate, it requires a heat press process that is a combination of time, temperature and pressure. The heat press applies this special combination, which can change depending on the substrate, to "transfer" the sublimation dyes at the molecular level into the substrate. The most common dyes used for sublimation activate at 175 °C. However, a range of 195 °C to 215 °C is normally recommended for optimal color. The result of the sublimation process is a nearly permanent, high resolution, full color print.
The development of the chemistry of alkaloids was accelerated by the emergence of spectroscopic and chromatographic methods in the 20th century, so that by 2008 more than 12,000 alkaloids had been identified. The first complete synthesis of an alkaloid was achieved in 1886 by the German chemist Albert Ladenburg. He produced coniine by reacting 2-methylpyridine with acetaldehyde and reducing the resulting 2-propenyl pyridine with sodium.
The calcium ion concentration in the cytosol of the beta cells can also, or additionally, be increased through the activation of phospholipase C resulting from the binding of an extracellular ligand (hormone or neurotransmitter) to a G protein-coupled membrane receptor. Phospholipase C cleaves the membrane phospholipid, phosphatidyl inositol 4,5-bisphosphate, into inositol 1,4,5-trisphosphate and diacylglycerol. Inositol 1,4,5-trisphosphate (IP3) then binds to receptor proteins in the plasma membrane of the endoplasmic reticulum (ER). This allows the release of Ca2+ ions from the ER via IP3-gated channels, which raises the cytosolic concentration of calcium ions independently of the effects of a high blood glucose concentration. Parasympathetic stimulation of the pancreatic islets operates via this pathway to increase insulin secretion into the blood. The significantly increased amount of calcium ions in the cells' cytoplasm causes the release into the blood of previously synthesized insulin, which has been stored in intracellular secretory vesicles. This is the primary mechanism for release of insulin. Other substances known to stimulate insulin release include the amino acids arginine and leucine, parasympathetic release of acetylcholine (acting via the phospholipase C pathway), sulfonylurea, cholecystokinin (CCK, also via phospholipase C), and the gastrointestinally derived incretins, such as glucagon-like peptide-1 (GLP-1) and glucose-dependent insulinotropic peptide (GIP).
=== Weight loss === Bupropion, when used for treating long-term weight gain over six to twelve months, results in an average weight loss of 2.7 kilograms (6.0 lb) compared to a placebo. This is not much different from the weight loss produced by several other weight-loss medications, such as sibutramine and orlistat. The combination drug naltrexone/bupropion has been approved by the US Food and Drug Administration (FDA) for the treatment of obesity.
== History == Prosenjit Choudhury was, at the time, a culinary expert at Sayaji Hotels. While working at the hotel, he introduced the concept of live grills similar to Korean barbecue in order to enhance the buffet experience to avoid cold appetisers. This idea proved to be popular and with the support of Sajid Dhanani, the managing director of Sayaji Hotels, Choudhury established the first outlet at Pali Hill in Mumbai, India in 2006. The brand had expanded to cities such as New Delhi and Bengaluru by 2008. After Sajid Dhanani's death in 2012, his brother Kayum Dhanani took over the business. The company opened its 100th outlet in 2018. The company offered its IPO in 2021. The IPO raised ₹453 crore (US$52 million), with ₹180 crore as fresh capital for expansion and debt repayment, and ₹273 crore as an offer for sale by existing investors. The stock was reported to perform poorly, due to factors such as the COVID-19 pandemic's impact on the restaurant market, weakening sales and increased competition. An Indian Express article highlighted how the buffet business was stalling due to new customer trends, affecting the growth of Barbeque Nation. As of 2022, the company owns an 86.57% stake in Red Apple Kitchen Consultancy Private Limited, which manages an Italian restaurant chain, Toscano.
Sources: en.wikipedia.org
No. It is a synthetic peptide fragment modeled on part of human growth hormone, not the full hormone. It does not contain the complete sequence or receptor-binding regions of hGH.
It was investigated in clinical trials for obesity, but it did not receive approval for that use in major markets. Results were generally modest or mixed, and it remains an experimental compound.
WADA lists it as a prohibited peptide hormone. Its use can be detected by laboratory methods, and athletes are subject to sanctions if it is found in samples.
AOD-9604 is a synthetic peptide fragment of human growth hormone. It corresponds to the C-terminal region known as hGH 176-191 and is studied for metabolic effects. It is not an approved therapeutic drug.